William W. Thompson, PhD Immunization Safety Office Office of the Chief Science Officer Centers for Disease Control and Prevention Impact of Seasonal Influenza.

Slides:



Advertisements
Similar presentations
Evolution of ACIP Influenza Vaccination Recommendations: Promise and Challenge Overview of the Path to Expanded Recommendations Anthony Fiore, MD, MPH.
Advertisements

INFLUENZA DIVISION U.S. Influenza Surveillance Update, Season Joseph Bresee, MD Epidemiology and Prevention Branch, Influenza Division, CDC VRBPAC.
Laurin Kasehagen, MA, PhD MCH Epidemiologist / CDC Assignee to CityMatCH Maternal & Child Health Epidemiology Program Applied Sciences Branch, Division.
AMMI Canada /CPHA Co-developed Accredited Learning Activity December 3, 2014 Dat Tran, MD, MSc Staff Physician, Division of Infectious Diseases The Hospital.
Vaccine Update and Refresher for Immunizations: 2012 Krista D. Capehart, PharmD, MSPharm, AE-C David G. Bowyer, R. Ph. Assistant Professors of Pharmacy.
Influenza and Influenza Vaccine
DO HEALTHY CHILDREN NEED TO GET VACCINATED?. Rationale for childhood vaccination Annual influenza vaccine is widely recommended for children at high risk.
INFLUENZA (FLU) Management Presentation
Influenza Outbreaks and Cruise Ships Laura Martin 25 April 2002.
Lisa Grohskopf, MD, MPH Medical Officer Influenza Division Centers for Disease Control and Prevention U.S. Influenza Surveillance National Center for Immunization.
2012–2013 Influenza Season Epidemiology Lynn Sosa, MD Deputy State Epidemiologist Connecticut Department of Public Health 1.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
MODELLING INFLUENZA- ASSOCIATED MORTALITY USING TIME-SERIES REGRESSION APPROACH Stefan Ma, CStat, PhD Epidemiology & Disease Control.
Influenza Vaccination
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
Beth Anne Kelley AU/AUM.  Influenza is a contagious respiratory illness caused by influenza viruses  People over the age of 65 have greater risks of.
Public Health Update David Kirschke, MD Medical Director / Health Officer Northeast Tennessee Regional Health Office.
New York State Department of Health, Bureau of Immunization, August 2012.
EFFICACY AND EFFECTIVINESS OF INACTIVED INFLUENZA VIRUS VACCINE.
INFLUENZA VACCINE Health Promotion Project Lauren Studdard Auburn University MSN.
Incidence of Influenza in Ontario Following the Universal Influenza Immunization Campaign Dianne Groll PhD, University of Ottawa David J Thomson PhD, Queen’s.
20 Answers About Influenza
1 Universal Immunization Against Rare Diseases  How much is a child’s life worth?  The individual vs society.
Immunization in the Time of H1N1 Anne Schuchat, MD Rear Admiral, US Public Health Service Director, National Center for Immunization and Respiratory Diseases.
Title page Influenza and Older Adults COM R.
Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.
Stanislaus County It’s Not Flu as Usual It’s Not Flu as Usual Pandemic Influenza Preparedness Renee Cartier Emergency Preparedness Manager Health Services.
Influenza A H1N1: A Pandemic in Real Time – What’s Next? Danny Chen, MD FRCPC MSc Infectious Disease Specialist Grand Rounds, York Central Hospital September.
The Flu Rapid Reading Exercise. The Flu Every year, 10 percent to 20 percent of Americans get sick with the flu (influenza). For most people, the fever,
U.S. Influenza Surveillance Keiji Fukuda Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Influenza and the Nursing Home Population Julie L. Freshwater, PhD MPH Influenza Surveillance Coordinator 1.
Better Health. No Hassles. Prevention PAYS! It’s a FREE physical, It’s at work, and It’s $25.00 in your pocket.
Traumatic Brain Injury in the United States Emergency Department Visits, Hospitalizations, and Deaths 1995–2001 National Center for Injury Prevention and.
The Current Season: A Review of the Influenza Season Nancy J. Cox, Ph.D. Chief, Influenza Branch National Center for Infectious Diseases Centers.
1 Novel Influenza A H1N1 Outbreak: The Florida Response Epidemiology Perspective: Situation Update.
1 Using ESSENCE-FL and a serosurvey to estimate total influenza infections, 2009 Richard S. Hopkins, MD, MSPH Kate Goodin, MPH Mackenzie Weise, MPH Aaron.
Community Change By: Emily Alpers, Shirley Iler, Barbara Lentz, & Sharon Lumbert.
1 Vaccines and Related Biologic Products Advisory Committee (VRBPAC) May 16, 2007 FluMist ® Influenza Virus Vaccine Live, Intranasal Safety and Effectiveness.
DO HEALTHY PEOPLE NEED TO GET VACCINATED?. Rationale for vaccination of healthy adults Absenteeism due to influenza in the adult workforce impacts on.
NVAC Influenza Vaccine Recommendations and Strategies Subgroup Members: Jerome Klein (Chair), Jeff Davis, Jon Abramson, Carolyn Bridges, Nancy Cox, Ben.
BURDEN OF INFLUENZA: MORTALITY AND DEATH. Everyone is at risk  100 million people infected every year in Northern Hemisphere* *In North America, Europe,
By: Sarah Lombardi Is the Influenza Vaccination in the Geriatric Population Needed?
Vaccines and Related Biological Products Advisory Committee Meeting July 23, 2009 Novel influenza A (H1N1) Epidemiology Update Anthony Fiore, MD, MPH Influenza.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
Samar Musmar,MD,FAAFP Vice Dean for Clinical Affairs An-Najah National University Faculty of Medicine Head, Medicine and Society Dep. Flu Vaccination in.
Presentation Outline Introduction Reasons to Immunize Adults: Make the Case Myths vs. Facts Barriers to Adult Immunization The Ask Adult Immunization Resources.
Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults Featured Article: Peter T. Campbell, Ph.D., Christina C. Newton,
Flu vaccination programme: Phase 2 extension of the programme to children 2015/16 October 2015.
Trends in childhood asthma: NCHS data on prevalence, health care use and mortality Susan Lukacs, DO, MSPH Lara Akinbami, MD Infant, Child and Women’s Health.
Community Change By: Emily Alpers, Shirley Iler, Barbara Lentz, & Sharon Lumbert.
INFLUENZA DIVISION Update on the Epidemiology and Clinical Features of Novel H1N1 Joseph Bresee, MD Chief, Epidemiology and Prevention Branch Influenza.
2009 Pandemic H1N1 Influenza Epidemiology April 2009 – January 2010 Preliminary.
Lisa Grohskopf, MD, MPH U.S. Influenza Surveillance Season National Center for Immunization & Respiratory Diseases Influenza Division U.S. Food.
Progress in adolescent vaccination coverage levels in the United States National Immunization Conference Washington, DC March 31, 2011 Shannon Stokley,
U.S. Influenza Surveillance Ann Moen Influenza Branch NCID/CDC.
Prevention of Perinatal and Childhood Hepatitis B Virus Infections Background on Where We’ve Been Lisa Jacques-Carroll, MSW Immunization Services Division,
Date of download: 6/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Impact of Influenza Vaccination on Seasonal Mortality.
National Immunization Conference March 9, 2006 Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development.
Examining the Role of Viral Evolution on Seasonal Influenza Incidence
Influenza Vaccine Effectiveness Against Pediatric Deaths:
Establishment of Influenza Surveillance System in Liberia
Flu epidemiology in Scotland – season 2017/18
FORECASTING DEMAND OF INFLUENZA VACCINES AND TRANSPORTATION ANALYSIS.
ACIP Recommended Vaccines for Adults – By Age
The State of Pneumococcal Disease Prevention
Peng-jun Lu, MD, PhD1; Mei-Chun Hung, MPH, PhD1,2 ; Alissa C
The Hong Kong Medical Association Symposium on Influenza 2003
Craig Conlon MD, PhD, Employee Health Services Northern California
Influenza Vaccine Program Effectiveness in the United States
Influenza Experience: Highlights and Comments
Presentation transcript:

William W. Thompson, PhD Immunization Safety Office Office of the Chief Science Officer Centers for Disease Control and Prevention Impact of Seasonal Influenza in the US

Collaborators David Shay, CDC Influenza Branch Eric Weintraub, CDC, OCSO/ISO Lynnette Brammer, CDC Influenza Branch Nancy Cox, CDC Influenza Branch Joe Bresee, CDC Influenza Branch Keiji Fukuda, WHO

Impact of Seasonal Influenza in the US Describe variation in deaths in US –Seasonal Variation –Age Variation Describe alternative models for estimating influenza-associated morbidity and mortality Compare alternative model estimates Review estimates of influenza impact –Deaths –Hospitalizations –Other morbidity

Seasonal Variation in Deaths Currently, there are approximately 2.4 million deaths in the United States annually –65,000 Underlying Pneumonia and Influenza deaths No direct measure of impact of influenza Strong seasonal component in US deaths –Peaks typically occur in December and January –Peaks tend to be associated with increases in influenza activity

Seasonal Variation in All-Cause Deaths ( ) Jun-71Jun-72 Jun-73 Jun-74 Jun-75Jun-76Jun-77Jun-78Jun-79Jun-80Jun-81Jun-82Jun-83Jun-84Jun-85Jun-86Jun-87 Jun-88Jun-89Jun-90Jun-91Jun-92 Jun-93 Jun-94 Jun-95Jun-96Jun-97Jun-98Jun-99Jun-00Jun-01Jun-02 Year Weekly All-Cause Deaths

Seasonal Variation in Underlying P&I Deaths ( ) Jun-71Jun-72Jun-73Jun-74Jun-75Jun-76Jun-77Jun-78Jun-79Jun-80Jun-81Jun-82Jun-83Jun-84Jun-85Jun-86Jun-87Jun-88Jun-89Jun-90Jun-91Jun-92Jun-93Jun-94Jun-95Jun-96Jun-97Jun-98Jun-99Jun-00Jun-01Jun-02 Year Weekly P&I Deaths

Population Growth in Urban Areas of the US Year Millions

Population Growth in Numbers of Elderly in the US Millions Age Group

Age Variation in Numbers of Deaths in the US , , , , , , , , Yrs 5-14 Yrs Yrs25-34 Yrs35-44 Yrs45-54 Yrs55-64 Yrs65-74 Yrs75-84 Yrs 85+ Yrs Age Group Deaths

RR of All-Cause Death Versus Underlying P&I Death (NCHS 2000) years 5-14 years years25-34 years35-44 years45-54 years55-64 years65-74 years75-84 years 85+ years Age Group RR of Death due to All-Cause versus P&I

Alternative Models for Estimating Impact of Influenza in US Simonsen et al. (1997) –Linear Regression Model –Modeled National Center for Health Statistics (NCHS) weekly death data from Outcomes –Underlying P&I Deaths (Most specific) –All-Cause Deaths (Least specific, most sensitive) Model Y t = a + b*t +c*t 2 + d*cos (2 t  /52) + f*sin(2 t  /52) + e t

Simonsen et al Model Jul-89Jul-90Jul-91Jul-92Jul-93Jul-94Jul-95 P&I Deaths

Alternative Models for Estimating Impact of Influenza in US Thompson et al. (2003) –Poisson Regression Model –Modeled National Center for Health Statistics (NCHS) weekly death data from –Incorporated WHO Influenza Surveillance Data Outcomes –Underlying P&I Deaths (Most specific) –Underlying Respiratory & Circulatory Deaths –All-Cause Deaths (Least specific) Model Y t =  exp (a + b*t +c*t 2 + d*cos (2 t  /52) + f*sin(2 t  /52) + g * A(H1N1)% + h * A(H3N2)% + i * B%)

Circulation of A(H3N2) Viruses and Underlying P&I Deaths Year P&I Deaths Per 100,000 A(H3N2)% Positive P&I Death RateA(H3N2)% % 10% 20% 30% 40% 50% 60%

Alternative Models for Estimating Impact of Influenza in US Barker & Mullooly (1980;1982) Two Types of Baseline Rates –Peri-Season Baseline Rate October through May when influenza is not circulating above 10% –Summer Season Baseline June through September Excess Rate = (Flu Rate) – (Non Flu Baseline Rate)

Seasonal Variation in Underlying P&I Deaths Summer Baseline Summer Baseline Winter Baseline Influenza Period Influenza Period Jul-89 Sep-89Nov-89 Jan-90 Mar-90 May-90 Jul-90 Sep-90Nov-90 Jan-91 Mar-91 May-91 Jul-91 Sep-91Nov-91 Jan-92 Mar-92 May-92 Jul-92

Influenza-Associated All-Cause Deaths by Model in the US ( ) Alternative Models Annual Influenza-Associated Deaths in US 31,467 29,473 43,958 73,635 35, ,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 Simonsen 97Simonsen 05PeriSummerPoisson

Correlations Between Estimates of Influenza- Associated All-Cause Deaths In the US ( ) Simonsen 97Simonsen 05PeriSummerPoisson Simonsen Simonsen Peri Summer Poisson

Correlation Between Estimates for Simonsen 2005 and Peri-Season Models y = x R 2 = Simonsen 2005 Estimates Peri Season Estimates

Influenza-Associated Underlying R&C Death Rates by Age For Peri-Season Model < >= 85 Age Group Deaths Per 100,000

Influenza-Associated Underlying R&C Deaths by Age For Peri-Season Model Age Group Influenza-Associated Deaths ,945 2,457 3,651 5,017 6,220 13, ,500 5,000 7,500 10,000 12,500 15,000 < >= 85

Surveillance of Influenza-Associated Deaths Among Children in the US 2003/2004 influenza season was severe compared to other recent seasons, especially among children CDC implemented surveillance of childhood deaths associated with influenza Reviewed case reports, medical records, autopsy reports

Surveillance of Influenza-Associated Deaths Among Children in the US Results –153 deaths among children aged < 18 years –96 deaths among children aged < 5 years –29% of the children died within 3 days of onset of the illness –47% of the children had previously been healthy CDC made influenza deaths among children a national reportable condition in October 2004

Influenza-Associated Hospitalizations Thompson et al (2004) National Hospital Discharge Survey Examined data from Incorporated WHO Influenza Surveillance data Outcomes –Primary P&I (Most Specific) –Any Listed P&I –Primary R&C –Any-Listed R&C (Least Specific) Model Y t =  exp (a + b*t +c*t 2 + d*cos (2 t  /12) + f*sin(2 t  /12) + g * A(H1N1)% + h * A(H3N2)% + i * B%)

Influenza-Associated Primary R&C Hospitalization Rates By Age ( ) < 5 Yrs 5-49 Yrs Yrs65-69 Yrs70-74 Yrs75-79 Yrs80-84 Yrs 85+ Yrs Age Group Influenza-Associated Primary R&C Hospitalizations Per 100,000

Influenza-Associated Primary R&C Hospitalizations By Age ( ) Age Group Influenza-Associated Primary R&C Hospitalizations 20,031 34,867 29,447 18,301 26,501 27,516 28,578 40, ,000 20,000 30,000 40,000 50,000 < 5 Yrs 5-49 Yrs Yrs65-69 Yrs70-74 Yrs75-79 Yrs80-84 Yrs 85+ Yrs

Influenza-Associated Hospitalizations Among Children Aged < 5 Years By Study Barker (1982) Neuzil (2000) Izurieta (2000) Neuzil (2002) Thompson (2004) Iwane (2004) Study Hospitalizations Per 1,000 Person Years

Excess P&I Hospitalization Rates By Risk Status Barker & Mullooly (1980, 1982) Age (Years) Excess P&I Hospitalizations Per 100,000 Persons Low RiskHigh Risk

Other Influenza-Associated Morbidity Nichol et al (1999) LAIV Trial Aged –Severe febrile illness –Work days missed –Doctors visits –Antibiotic use Bridges at al (2000) TIV Trial Aged –Febrile illness –Worked days missed –Doctors visits

Summary and Recommendations Influenza infections are associated with substantial morbidity and mortality every year –Improve vaccine coverage for at-risk populations currently recommended for annual influenza vaccination by ACIP The very elderly are at substantially increased risk for influenza-associated morbidity and mortality –Encourage development of vaccines with improved immunogenicity for older adults The aging of the US population is leading to substantially more seasonal influenza-associated morbidity and mortality every year –Prepare public health officials for the increasing burden of disease associated with seasonal influenza over the next decade